Ozempic and Munjaro are two medications used to treat type 2 diabetes, but now they’re being used for weight loss. While they can be effective in lowering blood sugar levels, they also come with potential risks and dangers that patients should be aware of.
Ozempic is a once-weekly injection that contains semaglutide, a type of medication called a GLP-1 receptor agonist. It works by increasing insulin production in the pancreas and decreasing the amount of glucose produced by the liver. Munjaro, on the other hand, is a combination of two medications – semaglutide and the drug tirzepatide. It also works to lower blood sugar levels and reduce the risk of cardiovascular events.
While both medications can be effective in treating type 2 diabetes, they can also come with a range of potential side effects and risks. Here are some of the dangers of Ozempic and Munjaro that patients should be aware of:
- Pancreatitis: Both Ozempic and Munjaro have been linked to an increased risk of pancreatitis, a condition where the pancreas becomes inflamed. Symptoms can include severe abdominal pain, nausea, and vomiting. In some cases, pancreatitis can be life-threatening.
- Kidney problems: Both medications have been associated with kidney problems, including an increased risk of kidney failure. Patients with pre-existing kidney problems may be at higher risk.
- Thyroid cancer: There have been concerns raised about a potential link between GLP-1 receptor agonists like Ozempic and Munjaro and an increased risk of thyroid cancer. While the evidence is not yet conclusive, patients should be aware of this potential risk.
- Hypoglycemia: Both medications can cause low blood sugar levels, which can be dangerous if left untreated. Patients taking these medications should be careful to monitor their blood sugar levels and seek medical attention if they experience symptoms of hypoglycemia, such as dizziness, confusion, or seizures.
- Other side effects: In addition to the above dangers, Ozempic and Munjaro can also cause a range of other side effects, including nausea, diarrhea, constipation, and headaches.
While Ozempic and Munjaro can be effective in treating type 2 diabetes, patients should be aware of the potential dangers and risks associated with these medications. Before starting any new medication, patients should discuss the potential benefits and risks with their healthcare provider and carefully weigh the risks against the benefits. Regular monitoring and close communication with a healthcare provider can help patients manage any potential side effects or risks associated with these medications.
Ready to get started? We have eating disorder dietitians who provide eating disorder treatment in Huntsville, as well as virtual health throughout Alabama.
States where our Registered Dietitian Nutritionists we can see clients:
Alabama, Arizona, Colorado, California, Florida, Utah, Missouri, Kentucky, Texas, Michigan, Virginia, New York.
Looking for more support?
Fill out our contact form to request an appointment with one of our providers, and we’ll get back to you ASAP!